{"news_desk": "SundayBusiness", "print_page": "6", "section_name": "Your Money", "subsection_name": null, "byline": {"original": "By JEFF SOMMER", "person": [{"rank": 1, "role": "reported", "firstname": "Jeff", "organization": "", "lastname": "SOMMER"}]}, "abstract": "Jeff Sommer Strategies column; Pfizer is ruminating over deal to move its legal tax headquarters from New York to Dublin by buying Allergan; from purely financial viewpoint, tax inversions make sense for companies.", "type_of_material": "News", "word_count": "1251", "lead_paragraph": "The drug maker\u2019s latest move toward shifting its legal tax headquarters abroad has drawn scorn from politicians, but it\u2019s a shareholder-friendly tactic.", "pub_date": "2015-11-15T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "A Tax-Cutting Move That Pfizer Can Hardly Resist", "content_kicker": "Strategies", "print_headline": "A Tax Tactic Pfizer Can Hardly Resist  ", "kicker": "Strategies"}, "snippet": "The drug maker\u2019s latest move toward shifting its legal tax headquarters abroad has drawn scorn from politicians, but it\u2019s a shareholder-friendly tactic.", "multimedia": [{"height": 126, "url": "images/2015/11/15/business/15-STRA/15-STRA-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/11/15/business/15-STRA/15-STRA-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/11/15/business/15-STRA/15-STRA-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/11/15/business/15-STRA/15-STRA-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/11/15/business/15-STRA/15-STRA-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/11/15/business/15-STRA/15-STRA-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/11/15/your-money/a-tax-cutting-move-that-pfizer-can-hardly-resist.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Pfizer Inc", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Corporate Taxes", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Tax Shelters", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Allergan Inc", "name": "organizations"}, {"rank": "5", "is_major": "Y", "value": "Ireland", "name": "glocations"}, {"rank": "6", "is_major": "N", "value": "Americans for Tax Fairness", "name": "organizations"}], "blog": [], "_id": "564761ba38f0d853f8379dd7", "source": "The New York Times"}